These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 24366438)

  • 1. Role of P-glycoprotein in regulating cilnidipine distribution to intact and ischemic brain.
    Yano K; Takimoto S; Motegi T; Tomono T; Hagiwara M; Idota Y; Morimoto K; Takahara A; Ogihara T
    Drug Metab Pharmacokinet; 2014; 29(3):254-8. PubMed ID: 24366438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of docetaxel ("Taxotere") with human P-glycoprotein.
    Shirakawa K; Takara K; Tanigawara Y; Aoyama N; Kasuga M; Komada F; Sakaeda T; Okumura K
    Jpn J Cancer Res; 1999 Dec; 90(12):1380-6. PubMed ID: 10665657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel anticancer drug KRN5500 interacts with, but is hardly transported by, human P-glycoprotein.
    Takara K; Tanigawara Y; Komada F; Nishiguchi K; Sakaeda T; Okumura K
    Jpn J Cancer Res; 2000 Feb; 91(2):248-54. PubMed ID: 10761713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of P-glycoprotein inhibitors on cadmium accumulation in cultured renal epithelial cells, LLC-PK1, and OK.
    Endo T; Kimura O; Sakata M
    Toxicol Appl Pharmacol; 2002 Dec; 185(3):166-71. PubMed ID: 12498733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular pharmacokinetic aspects of reversal effect of itraconazole on P-glycoprotein-mediated resistance of anticancer drugs.
    Takara K; Tanigawara Y; Komada F; Nishiguchi K; Sakaeda T; Okumura K
    Biol Pharm Bull; 1999 Dec; 22(12):1355-9. PubMed ID: 10746169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines.
    van der Sandt IC; Blom-Roosemalen MC; de Boer AG; Breimer DD
    Eur J Pharm Sci; 2000 Sep; 11(3):207-14. PubMed ID: 11042226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P-glycoprotein limits the brain penetration of olopatadine hydrochloride, H1-receptor antagonist.
    Mimura N; Nagata Y; Kuwabara T; Kubo N; Fuse E
    Drug Metab Pharmacokinet; 2008; 23(2):106-14. PubMed ID: 18445990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro P-Glycoprotein-Mediated Transport of Tadalafil: A Comparison with Sildenafil.
    Higashi H; Watanabe N; Tamura R; Taguchi M
    Biol Pharm Bull; 2017; 40(8):1314-1319. PubMed ID: 28769012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Directional transcellular transport of bisoprolol in P-glycoprotein-expressed LLC-GA5-COL150 cells, but not in renal epithelial LLC-PK1 Cells.
    Tahara K; Kagawa Y; Takaai M; Taguchi M; Hashimoto Y
    Drug Metab Pharmacokinet; 2008; 23(5):340-6. PubMed ID: 18974611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of P-glycoprotein to bunitrolol efflux across blood-brain barrier.
    Matsuzaki J; Yamamoto C; Miyama T; Takanaga H; Matsuo H; Ishizuka H; Kawahara Y; Kuwano M; Naito M; Tsuruo T; Sawada Y
    Biopharm Drug Dispos; 1999 Mar; 20(2):85-90. PubMed ID: 10206323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is aspirin a substrate of MDR1/P-glycoprotein?
    Singh R; Naik T; Nigam A; Chatterjee S; Rajanna P; Shen H; Iyer R
    Xenobiotica; 2020 Oct; 50(10):1258-1264. PubMed ID: 32302241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P-glycoprotein limits oral availability, brain, and fetal penetration of saquinavir even with high doses of ritonavir.
    Huisman MT; Smit JW; Wiltshire HR; Hoetelmans RM; Beijnen JH; Schinkel AH
    Mol Pharmacol; 2001 Apr; 59(4):806-13. PubMed ID: 11259625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (R)- and (S)-[11C]verapamil as PET-tracers for measuring P-glycoprotein function: in vitro and in vivo evaluation.
    Luurtsema G; Molthoff CF; Windhorst AD; Smit JW; Keizer H; Boellaard R; Lammertsma AA; Franssen EJ
    Nucl Med Biol; 2003 Oct; 30(7):747-51. PubMed ID: 14499333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of In Vitro Passive Permeability in a P-gp-transfected LLC-PK1 Model on the Prediction of the Rat and Human Unbound Brain-to-Plasma Concentration Ratio.
    Nicolaï J; Chapy H; Gillent E; Saunders K; Ungell AL; Nicolas JM; Chanteux H
    Pharm Res; 2020 Aug; 37(9):175. PubMed ID: 32856111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of doxorubicin handling in the LLC-PK1 kidney epithelial cell line is mediated by both vesicle formation and P-glycoprotein drug transport.
    Crivellato E; Candussio L; Rosati AM; Decorti G; Klugmann FB; Mallardi F
    Histochem J; 1999 Oct; 31(10):635-43. PubMed ID: 10576412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal absorption of pimozide is enhanced by inhibition of P-glycoprotein.
    Morishita H; Okawa K; Ishii M; Mizoi K; Ito MA; Arakawa H; Yano K; Ogihara T
    PLoS One; 2020; 15(10):e0232438. PubMed ID: 33119612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between expression level of P-glycoprotein and daunorubicin transport in LLC-PK1 cells transfected with human MDR1 gene.
    Tanaka K; Hirai M; Tanigawara Y; Ueda K; Takano M; Hori R; Inui K
    Biochem Pharmacol; 1997 Mar; 53(5):741-6. PubMed ID: 9113094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P-glycoprotein restricts the penetration of oseltamivir across the blood-brain barrier.
    Ose A; Kusuhara H; Yamatsugu K; Kanai M; Shibasaki M; Fujita T; Yamamoto A; Sugiyama Y
    Drug Metab Dispos; 2008 Feb; 36(2):427-34. PubMed ID: 18039806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood-brain barrier (BBB) pharmacoproteomics: reconstruction of in vivo brain distribution of 11 P-glycoprotein substrates based on the BBB transporter protein concentration, in vitro intrinsic transport activity, and unbound fraction in plasma and brain in mice.
    Uchida Y; Ohtsuki S; Kamiie J; Terasaki T
    J Pharmacol Exp Ther; 2011 Nov; 339(2):579-88. PubMed ID: 21828264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of P-glycoprotein in the brain disposition of seletalisib: Evaluation of the potential for drug-drug interactions.
    Nicolas JM; Chanteux H; Nicolaï J; Brouta F; Viot D; Rosseels ML; Gillent E; Bonnaillie P; Mathy FX; Long J; Helmer E
    Eur J Pharm Sci; 2020 Jan; 142():105122. PubMed ID: 31678424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.